Skip to search formSkip to main contentSkip to account menu

ATP13A2 gene

Known as: ATP13A2, CLN12, ATPase, TYPE 13A2 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
&NA; ATP13A2 (also called PARK9), is a transmembrane endo‐/lysosomal‐associated P5 type transport ATPase. Loss‐of‐function… 
Highly Cited
2016
Highly Cited
2016
Forms of Parkinson's disease (PD) are associated with lysosomal and autophagic dysfunction. ATP13A2, which is mutated in some… 
2016
2016
We previously reported that pharmacological inhibition of a class of enzymes known as prolyl hydroxylase domain proteins (PHDs… 
2016
2016
Atp13a2 (Park9) gene encodes a transmembrane lysosomal P5‐type ATPase (ATP13A2), and its missense or truncation mutations leads… 
Review
2015
Review
2015
The importance of ATP13A2 (PARK9) in Parkinson's disease (PD) has emerged with the discovery that mutations in this gene cause… 
Highly Cited
2015
Highly Cited
2015
Accumulating evidence from genetic and biochemical studies implicates dysfunction of the autophagic-lysosomal pathway as a key… 
Highly Cited
2014
Highly Cited
2014
Kufor–Rakeb syndrome (KRS) is caused by loss-of-function mutations in ATP13A2 (PARK9) and characterized by juvenile-onset… 
Highly Cited
2012
Highly Cited
2012
Lysosomes are responsible for degradation and recycling of bulky cell material, including accumulated misfolded proteins and… 
Highly Cited
2011
Highly Cited
2011
Mutations in the ATP13A2 gene are associated with Kufor-Rakeb syndrome (KRS) and are found also in patients with various other… 
Highly Cited
2011